Related references
Note: Only part of the references are listed.Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action
Robert A. Floyd et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
In vivo characterization of several rodent glioma models by 1H MRS
Sabrina Doblas et al.
NMR IN BIOMEDICINE (2012)
Novel Therapies in Glioblastoma
James Perry et al.
NEUROLOGY RESEARCH INTERNATIONAL (2012)
Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model
Valerie L. Jacobs et al.
ASN NEURO (2011)
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2011)
Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy
Ting He et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches
Kathryn Beal et al.
RADIATION ONCOLOGY (2011)
In vivo detection of inducible nitric oxide synthase in rodent gliomas
Rheal A. Towner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Multiparametric Assessment of the Anti-glioma Properties of OKN007 by Magnetic Resonance Imaging
Philippe Garteiser et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
A human brainstem glioma xenograft model enabled for bioluminescence imaging
Rintaro Hashizume et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Glioma proteomics: Status and perspectives
Simone P. Niclou et al.
JOURNAL OF PROTEOMICS (2010)
Current Therapeutic Paradigms in Glioblastoma
Allison Quick et al.
REVIEWS ON RECENT CLINICAL TRIALS (2010)
Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study
Maxime Culot et al.
BRAIN RESEARCH (2009)
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
Rolf F. Barth et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme
Jeannette R. Flynn et al.
CANCER (2008)
Nitrones as therapeutics
Robert A. Floyd et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography
Taketoshi Asanuma et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Silencing of hypoxia inducible factor-1α by RNA interference attenuates human glioma cell growth in vivo
David L. Gillespie et al.
CLINICAL CANCER RESEARCH (2007)
Safety, tolerability and pharmacokinetics of escalating doses of NXY-O59 in healthy young and elderly subjects
Johan Wemer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
NXY-059: Review of neuroprotective potential for acute stroke
JJ Fong et al.
ANNALS OF PHARMACOTHERAPY (2006)
Nitrone-related therapeutics - Potential of NXY-059 for the treatment of acute ischaemic stroke
KR Maples et al.
CNS DRUGS (2004)
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window
SG Sydserff et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Share Paper
